Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Imidazole | HCID 795 | — |
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | Phosphorus oxychloride | HCID 24813 | — |
| Reactant | Uridine, 4′-C-azido-, 2′,3′-dibenzoate 5′-(3-chlorobenzoate) | HCID 11707205 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | 2-Methyltetrahydrofuran | HCID 7301 | — |
| Product | HCID 86621229 | HCID 86621229 | 91.7% |
Reaction Steps
A suspension of 30.0 g (47.5 mmol) 3-chlorobenzoic acid (2R,3S,4R,5R)-2-azido-3,4-bis-benzoyloxy-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-2-ylmethyl ester and 26.0 g (380 mmol) imidazole in 110 ml MeTHF was treated at room temperature with 19.2 g (189 mmol) triethylamine. The resulting mixture was treated at 10 to 20° C. within 30 minutes with 11.03 g (71.2 mmol) phosphorous oxychloride. The mixture was heated to 60° C. and stirred at this temperature for 5 hours. The mixture was then cooled to 15° C. and treated at this temperature with 125 ml water. The layers were separated and the aqueous layer was extracted with MeTHF (1×30 ml). From the organic layer MeTHF was completely removed by distillation and replaced by 250 ml acetonitrile. Water (50 ml) and methylene chloride (100 ml) were added and the layers were separated. The aqueous layer was extracted with methylene chloride (1×100 ml). The organic layer was filtered, the solvent was evaporated and the residue (34.2 g) dried in vacuo (<30 mbar) at 40° C. for 16 hours to afford 29.7 g (90.8%) of 3-chlorobenzoic acid (2R,3S,4R,5R)-2-azido-3,4-bis-benzoyloxy-5-(4-imidazol-1-yl-2-oxo-2H-pyrimidin-1-yl)-tetrahydro-furan-2-ylmethyl ester with an assay of 99.3% (area).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07632940B2 |
|---|
| Source dataset | uspto-grants-2009_12 |
|---|
| ORD ID | ord-f817ff1ca9a34952a1ab2f899608c182 |
|---|
| Source note | uspto-grants-2009_12 |
|---|